You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Suspected warfarin-induced hemorrhage may be caused by different brand of warfarin switching
- In: Hospital Pharmacy Section - Posters
- At: Beijing (China) (2007)
- Type: Poster
- Poster code: HPS-P-109
- By: HUNG, W. S. (En Chu Kong hospital, Taipei, China Taiwan)
- Co-author(s): Chen, C.Y. (En Chu Kong hospital, TAIPEI, China Taiwan)
- Abstract:
Aims: To report three clinical cases of warfarin-induced hemorrhage, which may result from switching to warfarin of a different brand. Case summary: These three patients have taken warfarin for a long period and theirs international normalized ratio (INR) were kept between 2.0 and 3.0. Since the original pharmaceutical factory supplies
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026